ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 55 filers reported holding ARALEZ PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $174,000 | -47.3% | 497,897 | +126.2% | 0.06% | -47.5% |
| Q1 2018 | $330,000 | +118.5% | 220,153 | +107.1% | 0.12% | +106.8% |
| Q4 2017 | $151,000 | -37.9% | 106,293 | 0.0% | 0.06% | -43.3% |
| Q3 2017 | $243,000 | +68.8% | 106,293 | 0.0% | 0.10% | +60.0% |
| Q2 2017 | $144,000 | -33.3% | 106,293 | +4.5% | 0.06% | -36.9% |
| Q1 2017 | $216,000 | – | 101,693 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 2,737,140 | $9,033,000 | 7.18% |
| DRILL CRAIG A | 584,600 | $1,929,000 | 3.80% |
| ARMISTICE CAPITAL, LLC | 2,664,000 | $8,791,000 | 3.35% |
| Healthcare Value Capital, LLC | 575,000 | $1,898,000 | 2.30% |
| Tiger Legatus Capital Management, LLC | 1,500,000 | $4,950,000 | 1.50% |
| Broadfin Capital, LLC | 4,106,990 | $13,553,000 | 1.32% |
| Kavi Asset Management, LP | 313,627 | $1,035,000 | 0.83% |
| Elk Creek Partners, LLC | 1,514,918 | $4,999,000 | 0.36% |
| Par Capital Management | 6,400,000 | $21,120,000 | 0.35% |
| Healthcare Value Capital, LLC | 75,000 | $248,000 | 0.30% |